Cresset, a leading provider of integrated in silico solutions for drug discovery announces the release of V9 – the latest version of its Flare platform for ligand-based and structure-based design, which includes a full integration of Spark™, Cresset’s bioisostere replacement solution. Flare users will be able to benefit from the range of capabilities brought by this integration […] The post Cresset integrates Spark in latest release of Flare – from novel idea generation to extensive optimization first appeared on World Pharma Today ..read more

The Medical Device Contract Manufacturing Market is currently seeing robust growth due to the increasing demand for advanced medical devices, the rising prevalence of chronic diseases, and the shift of medical device companies towards outsourcing to concentrate on their core competencies. Contract manufacturing offers multiple benefits such as cost-effectiveness, access to cutting-edge technologies, and faster […] The post Medical Device Contract Manufacturing Market To Double-Up first appeared on World Pharma Today ..read more

The FDA has released a preliminary guide to aid developers of drug-device combination products in creating essential drug delivery outputs- EDDOs that ensure consistent performance. Products covered by this guide include syringes, injectors, infusion products, nasal sprays, inhalers, nebulizers, and vaginal delivery systems. Information about the delivery devices must be included in the relevant investigational […] The post Latest FDA Guidelines Streamline Drug-Device Development first appeared on World Pharma Today ..read more

Throughout the last four to five years, there has been a persistent problem, which was noted by Willus Fisher, a doctoral candidate at UC Santa Barbara, while teaching pharmacology to students. He remarked that each year, he reiterated the trade-offs of precise dosing with an IV as opposed to an oral pill, in which one […] The post Precise Dosing Promised By New Drug Delivery Technology first appeared on World Pharma Today ..read more

European Pharmacopoeia, during its 179th session in June 2024, confirmed the removal of the rabbit pyrogen test- RPT from its monographs. As explained by the European Directorate for the Quality of Medicines- EDQM, the RPT has been the traditional method for detecting pyrogens. In June 2021, the European Pharmacopoeia Commission- EPC committed to replacing the […] The post European Pharmacopoeia Replaces Traditional Pyrogen Test first appeared on World Pharma Today ..read more

The biopharma industry is well-positioned to respond to upcoming patent expirations by pursuing mergers and acquisitions, according to a research note from Morgan Stanley. The report, dated July 11, states that products losing exclusivity through 2030 generate a combined $183.5 billion in annual sales, with Amgen, Bristol Myers Squibb, and Merck facing significant exposure of […] The post The 3B Impact of Patent Expirations On Biopharma Giants first appeared on World Pharma Today ..read more

1. Can you elaborate on the importance of merging human intelligence with AI technology in leveraging insights for successful commercialization strategies in the pharmaceutical industry? Although successful commercialization is achievable without AI, leveraging AI-driven insights can provide a significant competitive advantage by enabling faster, more informed decision-making. AI, with its ability to process vast datasets […] The post AI not just for data crunching but better patient outcomes – Dominic Marasco from Envision Pharma Group first appeared on World Pharma Today ..read more

Leading global technology solutions partner Envision Pharma Group (Envision) has launched 4Sight, a new AI and technology-enabled approach designed to help medical affairs teams optimize raw data and turn it into actionable insights for healthcare professionals. 4Sight represents Envision’s innovative method for navigating the medical affairs insight journey. Powered by OKRA.ai and Envision’s proprietary technology […] The post Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare first appeared on World Pharma Today ..read more

In Brussels, July 9th, 2024, Dr. Pascal Piedbois assumed a pivotal role at One2Treat, tasked with ensuring their offerings meet the rigorous standards of both patients and clinical sponsors. Founded by Marc Buyse, One2Treat is pioneering an innovative approach aimed at reducing trial sample sizes and accelerating patient access to new treatments. Their software integrates […] The post Doctor Pascal Leads Biopharma Advancements At One2Treat first appeared on World Pharma Today ..read more

The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a compound annual growth rate (CAGR) of 8.9%. This growth in the historical period is attributed to increasing prevalence of chronic diseases, stringent regulatory requirements, rising demand for clinical trials aimed at […] The post Clinical Trial Supplies Market To Reach .72 Bn In 2028 first appeared on World Pharma Today ..read more